Aims: To determine the baseline characteristics and glucose‐lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …

Aim: This study aimed to describe the pattern of weight change in people with type 2
diabetes (T2DM) over time and when using alternative treatment regimens. Methods: Data …

Aims This study evaluates the relationship between HbA1c and weight change outcomes by
anti-diabetic weight-effect properties in patients newly treated for type 2 diabetes; a …

Summary Background The DiRECT trial assessed remission of type 2 diabetes during a
primary care-led weight-management programme. At 1 year, 68 (46%) of 149 intervention …

Objective: The objective of this study was to quantify 1‐year weight gain associated with the
initiation of sulphonylurea (SU), metformin, insulin and thiazolidinedione (TZD) therapy in a …

This study investigated whether a newly developed, dietitian led, weight management
programme 'Weight No More'was effective at helping patients with type 2 diabetes, who are …

Aims To provide a systematic review and meta‐analysis of recent evidence on the
effectiveness of lifestyle‐based weight loss interventions for adults with type 2 diabetes …

Background: The majority of patients with type 2 diabetes mellitus (T2DM) are overweight or
obese. Obesity is a significant risk factor for increased morbidity and mortality in people with …

Aim To quantify the effect of weight loss on glycated haemoglobin (HbA1c) at group level,
based on data from published weight loss trials in overweight and obese patients with type 2 …

OBJECTIVE Identify determinants of weight gain in people with type 2 diabetes mellitus
(T2DM) allocated to intensive versus standard glycemic control in the Action to Control …